Comparing the Perioperative Analgesic Effect of Two Different Volumes of Local Anesthetic Solution in Erector Spinae Plane Block in Patients Undergoing Modified Radical Mastectomy
1 other identifier
interventional
52
1 country
1
Brief Summary
The aim of this study is to compare and evaluate the analgesic effects of ultrasound-guided Erector Spinae Plane block using low volumes and high concentrations versus high volumes and low concentrations in patients undergoing MRM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Sep 2022
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2022
CompletedFirst Submitted
Initial submission to the registry
November 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 23, 2022
CompletedFirst Posted
Study publicly available on registry
April 14, 2023
CompletedMay 3, 2023
April 1, 2023
3 months
November 18, 2022
April 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Total dose of morphine needed postoperatively
Total dose of morphine needed postoperatively
Through Study Completion Up to 1 Day
Secondary Outcomes (6)
Time to first rescue analgesia, starting after extubation
Through Study Completion over the first 24 hours postoperative
Duration of surgery
Through Study Completion 24 hours postoperative
Blood loss,
Through Study Completion,an average of 1day
Total dose of fentanyl required intraoperative (including induction dose)
Through study completion,an average of 1day
Pain score at 15, 30, 45 and 60 min., 3,6,12 and 24 h after surgery
through study completion,an average of 1day
- +1 more secondary outcomes
Study Arms (2)
Group 1
ACTIVE COMPARATORPatients will preoperatively receive low concentration-high volume U/S ESP block, and then the patient will be transferred to the operating room one syringe of 30ml bupivacaine 0.25% {15 ml bupivacaine 0.5% and 15ml normal saline}, for each patient.
Group 2
ACTIVE COMPARATORPatients will preoperatively receive high concentration-low volume U/S ESP block block, and then the patient will be transferred to the operating room one syringe of 15 ml bupivacaine 0.5% {15 ml bupivacaine 0.5% }, for each patien).
Interventions
Patients will preoperatively receive low concentration-high volume ultasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room ) one syringe of 30ml bupivacaine 0.25% {15 ml bupivacaine 0.5% and 15ml normal saline} for each patient
Patients will preoperatively receive high concentration-low volume ultasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room (one syringe of 15 ml bupivacaine 0.5% {15 ml bupivacaine 0.5% } for each patien).
Eligibility Criteria
You may qualify if:
- Age starting from 18 to 60 years.
- Genders eligible for study: female sex.
- ASA II-III.
- Patients undergoing modified radical mastectomy.
- Body mass index (BMI) from 18.5 to 30 kg/m2.
You may not qualify if:
- Patient refusal
- Known allergy to local anesthetics
- Bleeding disorders; platelets count \<50,000, prothrombin concentration \<60% or any coagulopathy disorder.
- Use of any anti-coagulants
- Inability to provide informed consent
- ASA IV
- Neurological disorders
- Patient with psychiatric disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Yasmina sayed Abdrabo Ismaelcollaborator
- Norhan Abdelaleem Alicollaborator
- Ahmed Shaker Ragabcollaborator
Study Sites (1)
Ahmed Abdalla Mohamed
Cairo, 11451, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed Abdalla Mohamed, M.D
Cairo University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Patients will be randomly allocated to one of the two groups by sealed closed envelop technique
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Anesthesia &I.C.U and Pain Clinic, Cairo University
Study Record Dates
First Submitted
November 18, 2022
First Posted
April 14, 2023
Study Start
September 9, 2022
Primary Completion
December 16, 2022
Study Completion
December 23, 2022
Last Updated
May 3, 2023
Record last verified: 2023-04